531 related articles for article (PubMed ID: 8211801)
1. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
Salikova VV; Nonikov VE; Belousov IuB
Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
Korzh OB
Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effectiveness of delayed-action theophylline preparations].
Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
[TBL] [Abstract][Full Text] [Related]
4. [Euphylong in patients with chronic obstructive airway diseases].
Kublik A; von Wichert P
Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
6. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
[TBL] [Abstract][Full Text] [Related]
7. [Euphylong in standard dosage: comparison with an international retard preparation for twice-daily administration in recommended dosage].
Siemon G; Huber W; Maier-Stocker P
Pneumologie; 1991 Nov; 45 Suppl 4():853-7. PubMed ID: 1812479
[TBL] [Abstract][Full Text] [Related]
8. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
Chuchalin AG; Tsoĭ AN; Zaĭtseva TM; Titova EV; Medani SM; Smirnov MV; Kaziakhmedov EA
Ter Arkh; 1995; 67(6):26-9. PubMed ID: 7667774
[TBL] [Abstract][Full Text] [Related]
9. [Prescription of Theostat 300 as a single evening dose].
Germouty J; Bida C; Moreau L
Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
[TBL] [Abstract][Full Text] [Related]
10. [Levels of blood theophylline in patients with acute bronchospasm].
Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
[TBL] [Abstract][Full Text] [Related]
11. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
[TBL] [Abstract][Full Text] [Related]
12. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
14. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
17. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
18. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
Andrasch R; Schmitz-Schumann M
Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].
Götz JK; Sauter R
Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482
[TBL] [Abstract][Full Text] [Related]
20. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
